Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1,280 | $1,758 | $1,589 | $1,642 |
| % Growth | -27.2% | 10.7% | -3.3% | – |
| Cost of Goods Sold | $750 | $698 | $643 | $629 |
| Gross Profit | $530 | $1,060 | $946 | $1,013 |
| % Margin | 41.4% | 60.3% | 59.5% | 61.7% |
| R&D Expenses | $227 | $198 | $174 | $154 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $534 | $493 | $432 | $393 |
| Sales & Mktg Exp. | $534 | $493 | $432 | $393 |
| Other Operating Expenses | $140 | $114 | -$8 | $40 |
| Operating Expenses | $901 | $805 | $705 | $643 |
| Operating Income | -$371 | $254 | $335 | $509 |
| % Margin | -29% | 14.5% | 21.1% | 31% |
| Other Income/Exp. Net | $874 | -$19 | $87 | $134 |
| Pre-Tax Income | $503 | $236 | $328 | $504 |
| Tax Expense | $126 | $103 | $78 | $127 |
| Net Income | $377 | $133 | $250 | $377 |
| % Margin | 29.5% | 7.5% | 15.8% | 22.9% |
| EPS | 0.64 | 0.23 | 0.43 | 0.65 |
| % Growth | 178.3% | -46.5% | -33.8% | – |
| EPS Diluted | 0.64 | 0.23 | 0.43 | 0.65 |
| Weighted Avg Shares Out | 586 | 587 | 578 | 577 |
| Weighted Avg Shares Out Dil | 590 | 586 | 582 | 580 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $3 | $3 | $3 |
| Interest Expense | $11 | $18 | $7 | $5 |
| Depreciation & Amortization | $140 | $114 | $99 | $96 |
| EBITDA | $654 | $368 | $434 | $605 |
| % Margin | 51.1% | 20.9% | 27.3% | 36.8% |